Home » EMA Calls for Contamination Risk Testing in Shared Manufacturing Facilities
EMA Calls for Contamination Risk Testing in Shared Manufacturing Facilities
January 10, 2013
Drug and active substance manufacturers in the EU need to determine the threshold for cross-contamination when multiple medical products are produced in shared facilities, according to draft guidance from the European Medicines Agency.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor